hotspot -WSS

hotspot

author：entertainment 2025-09-06 01:57:55 - browse：76

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Supreme Court wrestles with OxyContin maker's bankruptcy deal

WSS

EMA weighs against approval for Mirati's lung cancer drug

Leukemia patients are helped by Syndax's new type of therapy

Pregnancy discrimination could be enabled by AI

Hey, doctors: Don't be no

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

knowledge

hotspot

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

Why the advice to take all your antibiotics may be wrong

The high cost of giving birth even with insurance

Pharma patents targeted by Biden in move to slash drug prices

At least 13 dead in Texas as scorching temps continue

Radiology is caught between AI's potential and concern for patients

Trump demands the U.S. pay no more for drugs than other countries … again

Teach medical students about patients with intellectual disabilities

Medical leaders decry Supreme Court decision on affirmative action

Chemotherapy shortages won’t get better under Biden’s latest plan

leisure time

The biotech scorecard for the 2nd quarter: 12 industry events to watch

SCOTUS to consider access to abortion pill mifepristone

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Pregnancy discrimination could be enabled by AI

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

The woman behind the Dana Farber

focus

entertainment

entertainment

explore